How HIV researchers overcame setbacks and kept a vaccine trial going
About this episode
Scientists say research into a vaccine for HIV is further along than it’s ever been.
But Trump administration cuts to scientific research have set that effort back.
Including a promising trial for an HIV vaccine in Africa – which was shut down altogether.
NPR’s Ari Daniel has the story of how researchers there refused to give up.
Ari’s reporting for this story was supported by a grant from the Pulitzer Center. The Gates Foundation is a financial supporter of NPR.
This episode was produced by Mallory Yu and Kira Wakeam.
It was edited by Rebecca Davis and Courtney Dorning.
Our executive producer is Sami Yenigun.
See pcm.adswizz.com for information about our collection and use of personal data for sponsorship and to manage your podcast sponsorship preferences.
NPR Privacy Policy
Get every episode summarized
Each time Consider This from NPR publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Consider This from NPR
25 years after the 9/11 attacks, where does the trial stand?
Consider This from NPR
Are big AI companies gambling with our lives?
Consider This from NPR
After a difficult trial, how do jurors move on?
Consider This from NPR
The Smithsonian's leader is stepping down. Where does the Institution go from he...
Consider This from NPR